Bioengineering heterodimeric cytokines: turning promiscuous proteins into therapeutic agents
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bioengineering heterodimeric cytokines: turning promiscuous proteins into therapeutic agents
Authors
Keywords
-
Journal
Biotechnology & Genetic Engineering Reviews
Volume 29, Issue 2, Pages 149-174
Publisher
Informa UK Limited
Online
2013-08-02
DOI
10.1080/02648725.2013.801228
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antiproliferative Activity of IL-27 on Melanoma
- (2014) T. Yoshimoto et al. JOURNAL OF IMMUNOLOGY
- Site-Specific PEGylation of Therapeutic Proteins via Optimization of Both Accessible Reactive Amino Acid Residues and PEG Derivatives
- (2012) Chun Zhang et al. BIODRUGS
- Plasticity and cross-talk of Interleukin 6-type cytokines
- (2012) Christoph Garbers et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Prevention of Autoimmune Diabetes by Ectopic Pancreatic -Cell Expression of Interleukin-35
- (2012) M. Bettini et al. DIABETES
- Novel IL27p28/IL12p40 Cytokine Suppressed Experimental Autoimmune Uveitis by Inhibiting Autoreactive Th1/Th17 Cells and Promoting Expansion of Regulatory T Cells
- (2012) Ren-Xi Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Distinct subunit pairing criteria within the heterodimeric IL-12 cytokine family
- (2012) Lindsay L. Jones et al. MOLECULAR IMMUNOLOGY
- From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines
- (2012) Jacques Banchereau et al. NATURE IMMUNOLOGY
- The composition and signaling of the IL-35 receptor are unconventional
- (2012) Lauren W Collison et al. NATURE IMMUNOLOGY
- IL-12 family cytokines: immunological playmakers
- (2012) Dario A A Vignali et al. NATURE IMMUNOLOGY
- IL-35 Is a Novel Responsive Anti-inflammatory Cytokine — A New System of Categorizing Anti-inflammatory Cytokines
- (2012) Xinyuan Li et al. PLoS One
- Antitumor Activities of Interleukin-27 on Melanoma
- (2012) Hiroshi Nagai et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Interpreting mixed signals: the cell's cytokine conundrum
- (2011) Greg M Delgoffe et al. CURRENT OPINION IN IMMUNOLOGY
- Cutting Edge: Human Regulatory T Cells Require IL-35 To Mediate Suppression and Infectious Tolerance
- (2011) V. Chaturvedi et al. JOURNAL OF IMMUNOLOGY
- Neonatal Fc receptor and IgG-based therapeutics
- (2011) Timothy T. Kuo et al. mAbs
- New directions in the basic and translational biology of interleukin-27
- (2011) Elia D. Tait Wojno et al. TRENDS IN IMMUNOLOGY
- Treatment with IL-27 attenuates experimental colitis through the suppression of the development of IL-17-producing T helper cells
- (2010) Tetsumasa Sasaoka et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cells
- (2010) C. Cocco et al. BLOOD
- Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
- (2010) S. P. Kerkar et al. CANCER RESEARCH
- Biopharmaceutical drug targeting to the brain
- (2010) William M. Pardridge JOURNAL OF DRUG TARGETING
- IL-23-Mediated Psoriasis-Like Epidermal Hyperplasia Is Dependent on IL-17A
- (2010) H. L. Rizzo et al. JOURNAL OF IMMUNOLOGY
- IL-35 Stimulation of CD39+ Regulatory T Cells Confers Protection against Collagen II-Induced Arthritis via the Production of IL-10
- (2010) I. Kochetkova et al. JOURNAL OF IMMUNOLOGY
- A role for IL-27p28 as an antagonist of gp130-mediated signaling
- (2010) Jason S Stumhofer et al. NATURE IMMUNOLOGY
- IL-35-mediated induction of a potent regulatory T cell population
- (2010) Lauren W Collison et al. NATURE IMMUNOLOGY
- Conformational stability of pGEX-expressed Schistosoma japonicum glutathione S-transferase: A detoxification enzyme and fusion-protein affinity tag
- (2010) Warren Kaplan et al. PROTEIN SCIENCE
- Fc-Based Cytokines
- (2009) Jalal A Jazayeri et al. BIODRUGS
- Denileukin diftitox: a novel immunotoxin
- (2009) George Manoukian et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Regulation of immune responses by interleukin-27
- (2009) Hiroki Yoshida et al. IMMUNOLOGICAL REVIEWS
- Regulation of interleukin-12/interleukin-23 production and the T-helper 17 response in humans
- (2009) Lyudmila Lyakh et al. IMMUNOLOGICAL REVIEWS
- Interleukin-35: odd one out or part of the family?
- (2009) Lauren W. Collison et al. IMMUNOLOGICAL REVIEWS
- From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited
- (2009) Katia Boniface et al. IMMUNOLOGICAL REVIEWS
- IL-27 Directly Restrains Lung Tumorigenicity by Suppressing Cyclooxygenase-2-Mediated Activities
- (2009) M.-Y. Ho et al. JOURNAL OF IMMUNOLOGY
- Suppression of Regulatory T Cells by IL-12p40 Homodimer via Nitric Oxide
- (2009) S. Brahmachari et al. JOURNAL OF IMMUNOLOGY
- Functional Blocking Monoclonal Antibodies against IL-12p40 Homodimer Inhibit Adoptive Transfer of Experimental Allergic Encephalomyelitis
- (2009) S. Mondal et al. JOURNAL OF IMMUNOLOGY
- IL-27 Blocks RORc Expression to Inhibit Lineage Commitment of Th17 Cells
- (2009) C. Diveu et al. JOURNAL OF IMMUNOLOGY
- Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma
- (2009) Peng Hu et al. MOLECULAR IMMUNOLOGY
- Co-stimulatory modulation in rheumatoid arthritis: The role of (CTLA4-Ig) abatacept
- (2008) Ugo Fiocco et al. AUTOIMMUNITY REVIEWS
- IL-12 p40 homodimer, but not IL-12 p70, induces the expression of IL-16 in microglia and macrophages
- (2008) Malabendu Jana et al. MOLECULAR IMMUNOLOGY
- Network pharmacology: the next paradigm in drug discovery
- (2008) Andrew L Hopkins Nature Chemical Biology
- Protein therapeutics: a summary and pharmacological classification
- (2007) Benjamin Leader et al. NATURE REVIEWS DRUG DISCOVERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now